Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
1999-08-18
2002-08-20
Swartz, Rodney P (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C424S094300, C424S184100, C424S193100, C424S204100, C424S252100, C435S007800, C435S188000, C436S512000, C436S527000, C436S538000
Reexamination Certificate
active
06436652
ABSTRACT:
This invention relates to a method of detecting a pathogen using a virus.
More specifically, the invention relates to the detection of the pathogen
Brucella abortus
using the virus Brucella bacteriophage.
Brucellosis is a disease caused by the bacterial genus, Brucella, named after Dr. David Bruce who discovered the organism in 1887. The disease is zoonotic, although different species are usually found in specific domestic animals, such as cattle (
B. abortus
), swine (
B. suis
), sheep (
B. ovis
), goats (
B. melitensis
) and dogs (
B. canis
). The manifestations of these bacteria in animals are usually reproductive complications (aborted fetuses, inflamed uterus or orchitis). While vaccinations in animals have proven partially effective in offering protection, the vaccines are pathogenic for other animals and humans. Infection is passed to humans through the ingestion of milk, milk products, the handling of contaminated carcases or aborted fetuses, and by the contact of infected tissues or body fluids. The disease is rarely passed from human to human, and then usually by exposure to contaminated blood specimens. Brucella is the number one cause of laboratory acquired infection. The great majority of patients with the disease survive, but only a small percentage ever recover completely. Usually the people infected are subject to relapses of recurrent, or undulant, fever, incapacitation, nausea and arthritis.
Brucella is a highly infective organism which causes debilitating symptoms, and which can persist in the environment for months under the right conditions. There are no effective vaccines and only limited therapeutic recourses to the bacteria. In other words, Brucella is potentially a bacterial warfare agent. Accordingly, there is a need for an effective detection assay.
Methods are available for the detection of pathogenic bacteria, but these have limitations. Culturing bacteria from clinical specimens is sensitive but often requires selective media, several days of incubation and the right nutrients or conditions (Brucella needs 5-10% carbon dioxide). Common serological techniques are usually insensitive. The enzyme-linked immunosorbent assay is usually rapid, sensitive and specific but gives false-positive for
Staphylococcus aureus
protein A, requires a source of antibodies which is difficult to raise, and may not detect different strains of the same species.
The object of the present invention is to meet the above defined need for an effective detection assay for Brucella (specifically
Brucella abortus
) in the form of an assay for the detection of pathogenic bacteria by using bacteriophages, a type of virus that is specific for host bacteria.
Accordingly, the present invention relates to a method of detecting the presence of a pathogenic bacteria in a liquid sample using a bacteriophage specific to the bacteria comprising the steps of producing a bacteriophage stock; conjugating the bacteriophage stock to an enzyme; mixing the conjugated bacteriophage with a sample suspected of containing the bacteria; and detecting any changes resulting from a reaction of the conjugated bacteriophage with the bacteria.
More specifically, the invention relates to a method of detecting the presence of the bacteria
Brucella abortus
in a sample using virus Brucella comprising the steps of producing a stock of Brucella bacteriophage, conjugating the Brucella bacteriophage to the enzyme urease; mixing the conjugated Brucella bacteriophage with a sample suspected of containing the bacteria
Brucella abortus
; and detecting any changes resulting from a reaction of the conjugated Brucella bacteriophage with the
Brucella abortus.
REFERENCES:
patent: 4104126 (1978-08-01), Young
patent: 4657853 (1987-04-01), Freytag et al.
patent: 4797363 (1989-01-01), Teodoresco et al.
patent: 5310649 (1994-05-01), Ficht et al.
patent: 1 212 051 (1986-09-01), None
Eder et al, Structural and functional comparison of antibodies to common and specific determinants of papain and chymopapain. Immunochemistry, vol. 10, pp. 535-543, Mar. 1973.*
Ausubel et al. Current Protocols in Molecular Biology, Greene Publishing Assoc. And Wiley, Interscience, Toronto, vol. 1(Suppl. 13):, Section 1.11.4(1989).
Avrameas et al., “Coupling of Enzymes to Antibodies and Antigens”, Scand. J. Immunol. 8(Suppl.7):7-23(1978).
Chamberlain, “Evaluation of Live Tularemia Vaccine Prepared in a Chemically Defined Medium”, Applied Microbiology 13(2):232-235 (1965).
Day, “Sized of Immunoglobulins”, Advanced Immunochemistry, Williams & Wilkins Co., Baltimore (1972) p. 93.
Healey et al., “A rapid Semi quantitative Capillary Enzyme Immunoassay for Digoxin”, Clinica Chimica Acta. 134:51-58(1983).
Rigby, Chapter 6, “The Brucellaphages”, Nielsen and Duncan (ed.) Animal Brucellosis, CRC Press, Boca Raton, pp. 121-130 (1990).
Tortorello et al., “Microtiter Plate Assays for the Measurement of Phage Adsorption and Infection in Lactococcus”, Analytical Biochemistry 192:362-366 (1991).
Block et al., “A Phage-Linked Immunoabsorbant System for the Detection of Pathologically Relevant Antigens”, Bio Techniques 7(7):756-758 (1989).
Steensma et al., “An Enzyme-linked Immunosorbent Assay (ELISA) for PBS Z1, a Defective Phage ofBacillus subtilis”, J. gen. Virol. 44:741-746 (1979).
Steensma, H. Y., “Absorption of the Defective Phase PBS Z1 toBacillus subtilis168 Wt”, J. gen. Virol. 52:93-101.
Nielsen et al., “A Review of Enzyme Immunoassay for Detection of Antibody toBrucella abortusin Cattle”, Veterinary Immunology and Immunopathology 18:331-347 (1988).
Diaz et al., Chapter 6, “Laboratory Techniques in the Diagnosis of Human Brucellosis”, Young and Corbel (ed), Brucellosis: Clinical and Laboratory Aspects, CRC Press, Boca Raton, Florida, pp. 73-83 (1989).
Corbel, Michael J., Chapter 5, “Microbiology of the GenusBrucella”, Brucellosis: Clinical and Laboratory Aspects, pp. 53-72 (1989).
O'Sullivan et al., “Methods for the Preparation of Enzyme-Antibody Conjugates for Use in Enzyme Imunoassay”, Methods in Enzymology 73:147-166 (1981).
Cherwonogrodzky John W.
Lotfali Kamil
Her Majesty the Queen in right of Canada as represented by the
Swartz Rodney P
LandOfFree
Method of detecting a pathogen using a virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of detecting a pathogen using a virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting a pathogen using a virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2876283